NCT01943721View on ClinicalTrials.gov

A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Ocular HypertensionPrimary Open Angle Glaucoma
Interventions
DRUG

VISION5 Product

Trial Locations (1)

Unknown

Contact ForSight VISION5 for Trial Locations, Contact ForSight Vision5 For Trial Locations

All Listed Sponsors
lead

ForSight Vision5, Inc.

INDUSTRY

NCT01943721 - A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension | Biotech Hunter | Biotech Hunter